Prescient Therapeutics Limited (PTX.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -7.18 Million AUD | 3.62% |
| 2023 | -7.45 Million AUD | -39.25% |
| 2022 | -5.2 Million AUD | -30.8% |
| 2021 | -4.24 Million AUD | -20.77% |
| 2020 | -3.46 Million AUD | 18.95% |
| 2019 | -3.89 Million AUD | -53.8% |
| 2018 | -2.66 Million AUD | 4.19% |
| 2017 | -2.53 Million AUD | -115.37% |
| 2016 | -2.74 Million AUD | -3183.82% |
| 2015 | - AUD | 94.25% |
| 2014 | - AUD | -104.09% |
| 2013 | 1.78 Million AUD | 75.12% |
| 2012 | -1.95 Million AUD | -41.5% |
| 2011 | -1.28 Million AUD | 22.93% |
| 2010 | -1.67 Million AUD | 15.66% |
| 2009 | -1.06 Million AUD | 15.53% |
| 2008 | -1.76 Million AUD | 15.41% |
| 2007 | -4.75 Million AUD | 42.17% |
| 2006 | -4.78 Million AUD | -25.28% |
| 2005 | -3.72 Million AUD | 7.52% |
| 2004 | -4.13 Million AUD | -32.82% |
| 2003 | -3.34 Million AUD | -13.65% |
| 2002 | -2.74 Million AUD | 8.61% |
| 2001 | -2.99 Million AUD | -24.09% |
| 2000 | -2.41 Million AUD | 15.23% |
| 1999 | -2.84 Million AUD | -176.32% |
| 1998 | -1.03 Million AUD | 21.1% |
| 1997 | -1.3 Million AUD | -1432.82% |
| 1996 | 98.08 Thousand AUD | 476.95% |
| 1995 | 17 Thousand AUD | 101.41% |
| 1994 | -1.2 Million AUD | -1182.98% |
| 1993 | -94 Thousand AUD | -202.17% |
| 1992 | 92 Thousand AUD | -54.46% |
| 1991 | 202 Thousand AUD | -71.55% |
| 1990 | 710 Thousand AUD | 498.88% |
| 1989 | -178 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -10.26% |
| 2024 Q4 | -3.2 Million AUD | 0.0% |
| 2024 Q2 | -3.98 Million AUD | 0.0% |
| 2023 Q2 | -3.01 Million AUD | 0.0% |
| 2023 FY | - AUD | -39.25% |
| 2023 Q4 | -4.43 Million AUD | 0.0% |
| 2022 FY | - AUD | -30.8% |
| 2022 Q4 | -2.55 Million AUD | 0.0% |
| 2022 Q2 | -2.64 Million AUD | 0.0% |
| 2021 Q4 | -2.43 Million AUD | 0.0% |
| 2021 FY | - AUD | -20.77% |
| 2021 Q2 | -1.8 Million AUD | 0.0% |
| 2020 Q4 | -1.72 Million AUD | 0.0% |
| 2020 FY | - AUD | 18.95% |
| 2020 Q2 | -1.73 Million AUD | 0.0% |
| 2019 FY | - AUD | -53.8% |
| 2019 Q4 | -2.24 Million AUD | 0.0% |
| 2019 Q2 | -1.64 Million AUD | 0.0% |
| 2018 Q2 | -1.15 Million AUD | 0.0% |
| 2018 Q4 | -1.51 Million AUD | 0.0% |
| 2018 FY | - AUD | 4.19% |
| 2017 Q4 | -1.49 Million AUD | 0.0% |
| 2017 FY | - AUD | -115.37% |
| 2017 Q2 | -1.04 Million AUD | 0.0% |
| 2016 Q4 | -1.74 Million AUD | 0.0% |
| 2016 Q2 | 46.84 Thousand AUD | 0.0% |
| 2016 FY | - AUD | -3183.82% |
| 2015 Q4 | -40.7 Thousand AUD | 0.0% |
| 2015 FY | - AUD | 94.25% |
| 2015 Q2 | -12.49 Thousand AUD | 0.0% |
| 2014 Q4 | -34.9 Thousand AUD | 0.0% |
| 2014 Q2 | -427.15 Thousand AUD | 0.0% |
| 2014 FY | - AUD | -104.09% |
| 2013 Q4 | 18.48 Thousand AUD | -95.86% |
| 2013 Q3 | 446.75 Thousand AUD | 198.8% |
| 2013 FY | - AUD | 75.12% |
| 2013 Q2 | -452.19 Thousand AUD | 0.68% |
| 2013 Q1 | -455.29 Thousand AUD | 0.0% |
| 2012 Q1 | -321.67 Thousand AUD | 0.0% |
| 2012 FY | - AUD | -41.5% |
| 2012 Q4 | -455.29 Thousand AUD | 0.0% |
| 2012 Q3 | -455.29 Thousand AUD | 0.0% |
| 2012 Q2 | -455.29 Thousand AUD | -41.54% |
| 2011 Q4 | -321.67 Thousand AUD | 0.0% |
| 2011 Q3 | -321.67 Thousand AUD | 0.0% |
| 2011 Q2 | -321.67 Thousand AUD | 22.96% |
| 2011 Q1 | -417.54 Thousand AUD | 0.0% |
| 2011 FY | - AUD | 22.93% |
| 2010 Q1 | -266.57 Thousand AUD | 0.0% |
| 2010 Q4 | -417.54 Thousand AUD | 0.0% |
| 2010 FY | - AUD | 15.66% |
| 2010 Q3 | -417.54 Thousand AUD | 0.0% |
| 2010 Q2 | -417.54 Thousand AUD | -56.63% |
| 2009 Q2 | -266.57 Thousand AUD | 35.73% |
| 2009 Q4 | -266.57 Thousand AUD | 0.0% |
| 2009 Q1 | -414.74 Thousand AUD | 0.0% |
| 2009 FY | - AUD | 15.53% |
| 2009 Q3 | -266.57 Thousand AUD | 0.0% |
| 2008 Q4 | -414.74 Thousand AUD | 0.0% |
| 2008 Q1 | -608.48 Thousand AUD | 0.0% |
| 2008 FY | - AUD | 15.41% |
| 2008 Q2 | -414.74 Thousand AUD | 31.84% |
| 2008 Q3 | -414.74 Thousand AUD | 0.0% |
| 2007 Q1 | -1.15 Million AUD | 0.0% |
| 2007 Q3 | -608.48 Thousand AUD | 0.0% |
| 2007 FY | - AUD | 42.17% |
| 2007 Q4 | -608.48 Thousand AUD | 0.0% |
| 2007 Q2 | -608.48 Thousand AUD | 47.33% |
| 2006 FY | - AUD | -25.28% |
| 2006 Q2 | -1.15 Million AUD | 39.51% |
| 2006 Q3 | -1.15 Million AUD | 0.0% |
| 2006 Q1 | -1.9 Million AUD | 0.0% |
| 2006 Q4 | -1.15 Million AUD | 0.0% |
| 2005 FY | - AUD | 7.52% |
| 2005 Q1 | -1.96 Million AUD | 0.0% |
| 2005 Q4 | -1.9 Million AUD | 0.0% |
| 2005 Q3 | -1.9 Million AUD | 0.0% |
| 2005 Q2 | -1.9 Million AUD | 2.85% |
| 2004 Q3 | -1.96 Million AUD | 0.0% |
| 2004 Q2 | -1.96 Million AUD | -25.73% |
| 2004 FY | - AUD | -32.82% |
| 2004 Q1 | -1.56 Million AUD | 0.0% |
| 2004 Q4 | -1.96 Million AUD | 0.0% |
| 2003 FY | - AUD | -13.65% |
| 2003 Q3 | -1.56 Million AUD | 0.0% |
| 2003 Q4 | -1.56 Million AUD | 0.0% |
| 2003 Q2 | -1.56 Million AUD | -18.38% |
| 2003 Q1 | -1.32 Million AUD | 0.0% |
| 2002 Q2 | -1.32 Million AUD | -15.37% |
| 2002 Q3 | -1.32 Million AUD | 0.0% |
| 2002 Q4 | -1.32 Million AUD | 0.0% |
| 2002 FY | - AUD | 8.61% |
| 2002 Q1 | -1.14 Million AUD | 0.0% |
| 2001 Q2 | -1.14 Million AUD | -0.38% |
| 2001 FY | - AUD | -24.09% |
| 2001 Q4 | -1.14 Million AUD | 0.0% |
| 2001 Q1 | -1.14 Million AUD | 0.0% |
| 2001 Q3 | -1.14 Million AUD | 0.0% |
| 2000 Q3 | -1.14 Million AUD | 0.0% |
| 2000 FY | - AUD | 15.23% |
| 2000 Q1 | -712.49 Thousand AUD | 0.0% |
| 2000 Q2 | -1.14 Million AUD | -60.06% |
| 2000 Q4 | -1.14 Million AUD | 0.0% |
| 1999 FY | - AUD | -176.32% |
| 1999 Q1 | -257.85 Thousand AUD | 0.0% |
| 1999 Q2 | -712.49 Thousand AUD | -176.32% |
| 1999 Q4 | -712.49 Thousand AUD | 0.0% |
| 1999 Q3 | -712.49 Thousand AUD | 0.0% |
| 1998 FY | - AUD | 21.1% |
| 1998 Q4 | -257.85 Thousand AUD | 0.0% |
| 1998 Q3 | -257.85 Thousand AUD | 0.0% |
| 1998 Q2 | -257.85 Thousand AUD | 21.1% |
| 1998 Q1 | -326.81 Thousand AUD | 0.0% |
| 1997 Q2 | -326.81 Thousand AUD | -1432.85% |
| 1997 FY | - AUD | -1432.82% |
| 1997 Q3 | -326.81 Thousand AUD | 0.0% |
| 1997 Q1 | 24.52 Thousand AUD | 0.0% |
| 1997 Q4 | -326.81 Thousand AUD | 0.0% |
| 1996 FY | - AUD | 476.95% |
| 1996 Q4 | 24.52 Thousand AUD | 0.0% |
| 1996 Q3 | 24.52 Thousand AUD | 0.0% |
| 1996 Q2 | 24.52 Thousand AUD | 476.94% |
| 1996 Q1 | 4250.00 AUD | 0.0% |
| 1995 FY | - AUD | 101.41% |
| 1995 Q4 | 4250.00 AUD | 0.0% |
| 1995 Q3 | 4250.00 AUD | 0.0% |
| 1995 Q2 | 4250.00 AUD | 101.41% |
| 1995 Q1 | -301.5 Thousand AUD | 0.0% |
| 1994 Q1 | -23.5 Thousand AUD | 0.0% |
| 1994 FY | - AUD | -1182.98% |
| 1994 Q4 | -301.5 Thousand AUD | 0.0% |
| 1994 Q3 | -301.5 Thousand AUD | 0.0% |
| 1994 Q2 | -301.5 Thousand AUD | -1182.98% |
| 1993 Q3 | -23.5 Thousand AUD | 0.0% |
| 1993 Q2 | -23.5 Thousand AUD | -232.39% |
| 1993 Q1 | 17.75 Thousand AUD | 0.0% |
| 1993 Q4 | -23.5 Thousand AUD | 0.0% |
| 1993 FY | - AUD | -202.17% |
| 1992 Q3 | 17.75 Thousand AUD | 0.0% |
| 1992 Q4 | 17.75 Thousand AUD | 0.0% |
| 1992 FY | - AUD | -54.46% |
| 1992 Q1 | -4500.00 AUD | 0.0% |
| 1992 Q2 | 17.75 Thousand AUD | 494.44% |
| 1991 Q4 | -4500.00 AUD | 0.0% |
| 1991 Q3 | -4500.00 AUD | 0.0% |
| 1991 FY | - AUD | -71.55% |
| 1991 Q2 | -4500.00 AUD | -101.98% |
| 1991 Q1 | 227.5 Thousand AUD | 0.0% |
| 1990 Q2 | 227.5 Thousand AUD | 437.04% |
| 1990 Q4 | 227.5 Thousand AUD | 0.0% |
| 1990 Q3 | 227.5 Thousand AUD | 0.0% |
| 1990 Q1 | -67.5 Thousand AUD | 0.0% |
| 1990 FY | - AUD | 498.88% |
| 1989 Q3 | -67.5 Thousand AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| 1989 Q4 | -67.5 Thousand AUD | 0.0% |
| 1989 Q2 | -67.5 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AdAlta Limited | -5.3 Million AUD | -35.51% |
| Acrux Limited | -7.93 Million AUD | 9.397% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -57.595% |
| Biome Australia Limited | -1.57 Million AUD | -355.295% |
| BTC Health Limited | 1.05 Million AUD | 780.924% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | 36.408% |
| CSL Limited | 4.73 Billion AUD | 100.152% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 83.906% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 113.855% |
| Noxopharm Limited | -5.94 Million AUD | -20.86% |
| PharmAust Limited | -9.45 Million AUD | 23.975% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | 8.896% |
| PYC Therapeutics Limited | -38.11 Million AUD | 81.149% |
| Race Oncology Limited | -14.2 Million AUD | 49.408% |
| Starpharma Holdings Limited | -12.57 Million AUD | 42.866% |
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 169.257% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | 48.376% |
| Memphasys Limited | -3.3 Million AUD | -117.24% |
| Nyrada Inc. | -4.59 Million AUD | -56.34% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -393.298% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 131.288% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -141.537% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 80.281% |
| Patrys Limited | -3.49 Million AUD | -105.767% |
| Dimerix Limited | -24.95 Million AUD | 71.209% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 103.606% |
| Orthocell Limited | -11.68 Million AUD | 38.484% |
| Imugene Limited | -147.97 Million AUD | 95.144% |
| Cynata Therapeutics Limited | -9.95 Million AUD | 27.783% |
| Immutep Limited | -42.87 Million AUD | 83.24% |
| Arovella Therapeutics Limited | -8.83 Million AUD | 18.651% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 63.285% |
| Nanollose Limited | -1.14 Million AUD | -525.986% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -897.403% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -300.031% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -154.982% |
| Biotron Limited | -5.04 Million AUD | -42.572% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 84.164% |
| Tissue Repair Ltd | -5.77 Million AUD | -24.428% |
| AnteoTech Limited | -11.57 Million AUD | 37.899% |
| Hexima Limited | -995.54 Thousand AUD | -621.787% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 88.866% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 66.35% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -121.609% |
| Actinogen Medical Limited | -12.92 Million AUD | 44.388% |
| Immuron Limited | -6.19 Million AUD | -16.041% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -278.675% |